Purchase Order 75N93019P01056

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qlucore Inc. for $14,435.00 on June 1, 2018, with completion by August 31, 2019. The order is firm fixed price with no set-aside. Work is performed in New York, New York. The purchase covers Qlucore Ambis software licensing for research data analysis and visualization supporting the institute's infectious disease research mission.</p>

<p>The National Cancer Institute awarded a purchase order to Qlucore Inc. for $23,596.00 on January 15, 2020, with final completion scheduled for February 17, 2020. No set-aside was used. Performance occurs in New York, New York. The order procures scientific software licensing, specifically Qlucore Omics Explorer with data analysis capabilities for research institutions. Pricing is firm fixed price.</p>

This is a federal contract award to Qlucore Inc., a foreign-owned, for-profit organization, by the National Cancer Institute (NCI), which is part of the U.S. Department of Health and Human Services. The contract provides Qlucore's Qlucore Omics Explorer software, including four academic floating licenses (four concurrent users) and one next-generation sequencing (NGS) add-on floating license. The total ceiling value of the contract is $21,860.00, and it is a firm-fixed-price purchase order....

<p>The National Cancer Institute awarded a purchase order to Qlucore Inc. for $5,549.00 on April 16, 2018, with final completion on May 12, 2018. No set-aside was used. The order covers software licensing—specifically Qlucore Omics Explorer, the vendor's data analysis platform for genomics and cancer research. Performance is at Bethesda, Maryland.</p>

The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for $13,936.20 in QIAcube-compatible QIAseq sequencing kits on September 13, 2021, with ultimate completion on July 7, 2022. The order was issued to de-obligate unexpiring fiscal year 2021 funds in accordance with 31 U.S.C. Section 1552(a) ahead of the September 30, 2026 period-of-availability close. Performance takes place in Germantown, Maryland. The purchase order carries firm fixed price pricing...

<p>The National Cancer Institute awarded a purchase order to Qlucore Inc. for $4,624.00 on March 13, 2018, with ultimate completion on April 13, 2018. No set-aside was used. Performance occurs in Bethesda, Maryland. The order procures scientific software licensing, specifically Qlucore Omics Explorer for data visualization and analysis in genomics and cancer research applications.</p>

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $43,587.50 firm fixed price purchase order to Qiagen, LLC for one catalog item #834083, HGMD Data Download for clinical use by a medium-sized enterprise. The place of performance will be Qiagen's Germantown, Maryland division. The period of performance is January 1, 2024 through November 25, 2024. No set aside designation or subcontractors were indicated....

The National Institute of Allergy and Infectious Diseases awarded a purchase order to 10X Genomics, Inc. on July 1, 2020, with a ceiling value of $22,817.50 for genomic analysis equipment and reagents. The order was a firm fixed-price acquisition without set-aside designation. Performance is located in Bethesda, Maryland, with an ultimate completion date of July 31, 2020. The purchase order procures specialized genomic research consumables and instruments, including single-cell analysis kits and...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $14,722.93 firm fixed price purchase order to AB Sciex LLC for total service coverage for a PA 800 Plus CGE instrument. The place of performance will be AB Sciex LLC's Redwood City, California facility. The period of performance is one year, starting on February 19, 2024 through February 18, 2025. No set aside designation or subcontractors were indicated....

The National Institute of Allergy and Infectious Diseases awarded a $17,013.02 firm fixed-price purchase order to Qiagen, LLC for the QIASEQ FastSelect 5S/16S/23S Kit (384). This contract, awarded on September 16, 2021, with an ultimate completion date of September 24, 2021, represents a straightforward procurement of specialized molecular biology reagents used for ribosomal RNA depletion and sample preparation in next-generation sequencing applications. The award includes no set-aside...